MicroRNA‐130a, a Potential Antifibrotic Target in Cardiac Fibrosis

BACKGROUND: Cardiac fibrosis occurs because of disruption of the extracellular matrix network leading to myocardial dysfunction. Angiotensin II has been implicated in the development of cardiac fibrosis. Recently, microRNAs have been identified as an attractive target for therapeutic intervention in...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li, Bounds, Kelsey R., Chatterjee, Piyali, Gupta, Sudhiranjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721768/
https://www.ncbi.nlm.nih.gov/pubmed/29114000
http://dx.doi.org/10.1161/JAHA.117.006763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721768/
https://www.ncbi.nlm.nih.gov/pubmed/29114000
http://dx.doi.org/10.1161/JAHA.117.006763

Ejemplares similares